Business
This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 34% on Good News. - Barron's
What the report says
AbCellera stock surges. New data show a single dose of its menopause treatment, ABCL635, reduces how often patients with menopause experience hot flashes.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Capital Markets Authority Joins Corporate Run to Raise Funds for 5,000 Mama KitsNile Post
Uber exit calls for regulation of global brands to protect usersThe Observer
PDM Financing Hits Shs4.3 Trillion , Reaches 3.5 Million BeneficiariesNile Post
Uganda, China Seek to Deepen Trade and Investment CooperationNile Post
What changes consumer behavior beyond communicationThe Independent Uganda